Geneoscopy fetches $105m Series B

Geneoscopy Inc., a life sciences company focused on the development of diagnostic tests for gastrointestinal health, has raised $105 million in Series B financing.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this